A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition ...
Novo Nordisk A/S expects sales to surge again this year as the Danish drugmaker builds supply for blockbuster diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback